Literature DB >> 9364037

Late pulmonary impairment following allogeneic bone marrow transplantation.

T Beinert1, T Düll, K Wolf, E Holler, C Vogelmeier, J Behr, H Kolb.   

Abstract

The pulmonary function of 88 consecutive leukemic patients who had undergone allogeneic bone marrow transplantation (BMT) was studied beforehand, at 3 months, at 6 months, and annually thereafter until 5 years after grafting. The parameters for function which are indicative for obstructive and restrictive lung disease deteriorated in all patient groups during the first 3 to 6 months after BMT but partially recovered within one year. Long-term decline in lung function was similar in all patient groups, and neither the onset nor the magnitude of pulmonary dysfunction was related to the occurrence of pulmonary impairment within 6 months after grafting. Multivariate analysis was then employed to assess predictors for long-term pulmonary disease. Despite the obvious effect of chronic graft versus host disease on the course of lung function, it was in itself not a significant predictor of long-term pulmonary outcome. Rather, the conditioning regimen turned out to be indicative; compared with busulfan, fractionated total body irradiation was demonstrated to be clearly superior with a lower incidence of both restrictive and obstructive long-term lung impairment. Our data indicate a previously unknown long-term side effect of busulfan conditioning.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9364037

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  9 in total

1.  Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation.

Authors:  Jason W Chien; Lue Ping Zhao; John A Hansen; Wen Hong Fan; Tanyalak Parimon; Joan G Clark
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

2.  Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantation.

Authors:  Filippo Milano; Margaret A Au; Michael J Boeckh; H Joachim Deeg; Jason W Chien
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-22       Impact factor: 5.742

3.  Late pulmonary sequelae after childhood bone marrow transplantation.

Authors:  I Cerveri; M C Zoia; P Fulgoni; A Corsico; L Casali; C Tinelli; M Zecca; G Giorgiani; F Locatelli
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

4.  Stable long-term pulmonary function after myeloablative double cord blood transplant.

Authors:  Filippo Milano; Jason W Chien; Ivy Riffkin; Jonathan A Gutman; Laura Newell; Steven A Pergam; Colleen Delaney
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-11       Impact factor: 5.742

5.  Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.

Authors:  Bipin N Savani; Aldemar Montero; Ramaprasad Srinivasan; Anurag Singh; Aarthi Shenoy; Stephan Mielke; Katayoun Rezvani; Shervin Karimpour; Richard Childs; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2006-12       Impact factor: 5.742

Review 6.  Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes.

Authors:  John A Hansen; Effie W Petersdorf; Ming-Tseh Lin; Steven Wang; Jason W Chien; Barry Storer; Paul J Martin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 7.  Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.

Authors:  Jason W Chien; Steven Duncan; Kirsten M Williams; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-05       Impact factor: 5.742

8.  Repair of impaired pulmonary function is possible in very-long-term allogeneic stem cell transplantation survivors.

Authors:  Natasha A Jain; Priyanka A Pophali; Jeffrey K Klotz; Sawa Ito; Eleftheria Koklanaris; Kamna Chawla; Christopher S Hourigan; Nicole Gormley; Bipin N Savani; Austin John Barrett; Minoo Battiwalla
Journal:  Biol Blood Marrow Transplant       Date:  2013-11-02       Impact factor: 5.742

9.  Characteristics of Traditional Chinese Medicine Use in Pediatric Cancer Patients: A Nationwide, Retrospective, Taiwanese-Registry, Population-Based Study.

Authors:  Hung-Rong Yen; Wan-Yu Lai; Chih-Hsin Muo; Mao-Feng Sun
Journal:  Integr Cancer Ther       Date:  2016-07-12       Impact factor: 3.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.